Form 4: Annexon EVP Acquires Shares and Options in Recent Transaction

Dean Richard Artis, EVP & Chief Scientific Officer of Annexon, Inc., reports acquisition of shares and stock options.

Summary

• On February 27, 2024, Dean Richard Artis acquired 44,963 shares of Annexon, Inc. common stock at $0.
• Following this transaction, Artis directly owns 128,777 shares of common stock.
• Artis also acquired options to purchase 272,575 shares of common stock at an exercise price of $2.50 on February 27, 2025.
• These options vest monthly from February 27, 2025, over four years.
• Artis will receive one share of common stock for each of the 44,963 restricted stock units (RSUs) upon vesting, with 1/3 vesting annually starting February 27, 2026.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a standard regulatory filing detailing stock and option acquisitions by an executive. The acquisitions themselves can be seen as a mildly positive sign, indicating confidence, but the filing itself is simply a procedural requirement.

Positives

• The acquisition of shares and options by a key executive could be seen as a positive signal about the executive's confidence in the company's future prospects.

Future Outlook

The document does not contain explicit forward-looking statements, but the vesting schedules for the options and RSUs suggest a multi-year commitment from the executive.

Industry Context

Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and confidence in the company.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment due to the executive's increased stake in the company.

Key Dates